Table 2.
Ingredients to develop new hydrocolloid films formulation which compromise VCN-2 and allantoin compound.
Formulation | Sodium alginate (g) | Drug compound-loaded X 10 −4 (g) | Gelatin (g) | Propylene glycol (g) | Glycerol (g) | Distilled water (g) |
---|---|---|---|---|---|---|
H1 | 4.5 | — | 4 | 15 | 6 | 70.500 |
(Blank) | ||||||
H2 | 4.5 | VCN-2 | 4 | 15 | 6 | 70.499 |
(VCN-2 12.5 μM) | 12.5 | |||||
H3 | 4.5 | VCN-2 | 4 | 15 | 6 | 70.498 |
(VCN-225 μM) | 25.0 | |||||
H4 | 4.5 | ALN | 4 | 15 | 6 | 70.495 |
(ALN316 μM) | 50.0 |
VCN: Vicenin; ALN: allantoin.